Table 1.
Baseline characteristics of individuals with or without NAFLD.
| Non‐NAFLD (n = 1324) | NAFLD (n = 2172) | |
|---|---|---|
| Age (years) | 49.28 ± 10.46 | 49.49 ± 9.86 |
| Sex (male/female) | 669/655 | 1755/417* |
| BMI (kg/m2) | 22.88 ± 2.20 | 26.78 ± 2.59* |
| SBP (mmHg) | 122.37 ± 17.14 | 130.45 ± 15.96* |
| DBP (mmHg) | 74.51 ± 11.03 | 81.13 ± 10.92* |
| FBG (mmol/L) | 5.26 ± 0.91 | 5.77 ± 1.44* |
| HbA1c (%) | 5.53 ± 0.57 | 5.78 ± 0.85* |
| TC (mmol/L) | 5.27 ± 1.04 | 5.41 ± 1.08* |
| TG (mmol/L) | 1.32 ± 0.68 | 2.25 ± 1.64* |
| LDL-C(mmol/L) | 3.22 ± 0.76 | 3.42 ± 0.77* |
| HDL-C(mmol/L) | 1.43 ± 0.32 | 1.21 ± 0.25* |
| Uric acid (mmol/l) | 311.08 ± 80.52 | 376.63 ± 83.21* |
| ALT (U/L) | 19.39 ± 10.43 | 30.93 ± 19.59* |
| AST (U/L) | 22.11 ± 7.21 | 25.39 ± 10.26* |
| GGT (U/L) | 25.57 ± 19.82 | 43.59 ± 28.96* |
| FT3 (pmol/L) | 4.77 ± 0.48 | 5.08 ± 0.59* |
| FT4 (pmol/L) | 16.96 ± 1.98 | 17.06 ± 1.95 |
| TSH (pmol/L) | 2.25 ± 0.83 | 2.20 ± 0.84 |
Values are presented as mean ± standard deviation.
BMI, body mass index; SBP, systolic blood pressure; DBP, diastolic blood pressure; FBG, fasting blood glucose; TC, total cholesterol; TG, triacylglyceride; LDL-C, high-density lipoprotein cholesterol; HDL-C, high-density lipoprotein cholesterol; ALT, alanine aminotransferase; AST, aspartate transaminase; GGT, gamma-glutamyl transpeptidase; FT3, free triiodothyronine; FT4, free thyroxine; TSH, thyroid‐stimulating hormone. Compared with non‐NAFLD, *P < 0.05.